Publications

5532 Results

Correlation of PML-RARa mRNA type with pretreatment clinical characteristics and achievement of complete remission (CR) in acute promyelocytic leukemia (APL): An Intergroup Laboratory study.

Authors
R Gallagher;C Willman;J Slack;J Andersen;Y Li;D Viswanatha;C Bloomfield;F Appelbaum;C Schiffer;M Tallman;P Wiernik
Journal / Conference
Blood 86(10)(Suppl.1)(#2902):729a
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Functions and organization of coordinating centers for multicenter studies.

Authors
BA Bumenstein;KE James;BK Lind;HE Mitchell
Journal / Conference
Controlled Clinical Trials 16:4S-29S
Year
1995

Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia (CLL). A randomized inter-group study.

Authors
KR Rai;B Peterson;J Kolitz;L Elias;L Shepherd;J Hines;B Cheson;C Schiffer
Journal / Conference
Blood 86(10)(Suppl.1)(#2414):607a
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

A review of tree-based prognostic models.

Authors
M LeBlanc;J Crowley
Journal / Conference
Recent Advances in Clinical Trial Design and Analysis :113-124
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

Step-function covariate effects in the proportional-hazards model.

Authors
M LeBlanc;J Crowley
Journal / Conference
The Canadian Journal of Statistics 23(2):109-129
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissectio and comparative genomic hybridization.

Authors
RN Wiltshire;P Duray;ML Bittner;T Visakorpi;PS Meltzer;RJ Tuthill;LA Liotta;JM Trent
Journal / Conference
Cancer Research 55:3954-3957
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Overview analysis issues using combined androgen deprivation overview analysis as an example.

Authors
BA Blumenstein
Journal / Conference
Urologic Oncology 1:95-100
Year
1995
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889)

Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group study.

Authors
E Kraut;J Crowley;J Wade;L Laufman;G Weiss;S Taylor;S Salmon
Journal / Conference
Blood 86(10)(Supl.1)(#726):185a
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9237

Exploratory methods in survival analysis.

Authors
J Crowley;M LeBlanc;R Gentleman;S Salmon
Journal / Conference
IMS Lecture Notes - Monograph Series 27:55-77
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

A study of the mechanism of IFN alfa-2b in high-risk melanoma in the ECOG/Intergroup trial E1690.

Authors
JM Kirkwood;J Sosman;M Ernstoff;M Ross;C Gerstner;J Bryant;T Whiteside;C Johnson
Journal / Conference
American Association for Cancer Research 36(#3815):641
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9325 (EST-2690)